[DOI] [PubMed] [Google Scholar] 36.Ilic S., Drmic D., Zarkovic K., Kolenc D., Brcic L., Radic B., Djuzel V., Blagaic A.B., Romic Z., Dzidic S., et al
[15] This complex consists of the following symptoms: Impaired perception of deep touch, pressure and vibration, loss of sense of touch, very annoying and persistent paresthesias Ataxia of dorsal column type Decrease or loss of deep muscle-tendon reflexes Pathological reflexes Babinski, Rossolimo and others, also severe paresis
Every milligram matters
Current availability is confined to the research-chemical market, without regulatory oversight or established human safety data
The mechanism through which it promotes fat loss, primarily beta-3 adrenergic receptor activation, is completely separate from IGF-1 signaling
An algorithm has been developed to assist physicians in diagnosing pancytopenia (Figure 2)